Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

284 trials with published results (19%)

Research Maturity

956 completed trials (64% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

9.2%

138 terminated out of 1502 trials

Success Rate

87.4%

+0.9% vs benchmark

Late-Stage Pipeline

22%

326 trials in Phase 3/4

Results Transparency

30%

284 of 956 completed with results

Key Signals

284 with results87% success138 terminated

Data Visualizations

Phase Distribution

1,176Total
Not Applicable (618)
Early P 1 (8)
P 1 (95)
P 2 (129)
P 3 (155)
P 4 (171)

Trial Status

Completed956
Unknown189
Terminated138
Recruiting65
Withdrawn62
Active Not Recruiting50

Trial Success Rate

87.4%

Benchmark: 86.5%

Based on 956 completed trials

Clinical Trials (1502)

Showing 20 of 20 trials
NCT06778486Not ApplicableActive Not RecruitingPrimary

Conversations in Health Literacy Using AI Technology for Osteoarthritis Patients

NCT06631638Not ApplicableRecruitingPrimary

EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))

NCT07487766Phase 1Not Yet RecruitingPrimary

The Safety and Efficacy of XytriX (Umbilical Cord-Derived Mesenchymal Stem Cells) in the Treatment of Knee Osteoarthritis

NCT02839850Not ApplicableActive Not RecruitingPrimary

14022 ATTUNE Cementless RP Clinical Performance Evaluation

NCT06744842Not ApplicableCompletedPrimary

Effect of Genicular Nerve Block on Proprioception in Knee Osteoarthritis

NCT06518278RecruitingPrimary

Assessing Central Aspects of Pain

NCT02539069Not ApplicableCompletedPrimary

The Post-marketing Surveillance to Evaluate the Efficacy of CHONDRON (Autologous Cultured Chondrocyte) by Arthroscopy

NCT02539056Not ApplicableCompletedPrimary

The Post-marketing Surveillance to Evaluate the Efficacy and Safety of a CHONDRON (Autologous Cultured Chondrocyte)

NCT04864392Phase 2TerminatedPrimary

Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis

NCT07489521Phase 4Recruiting

Arthrosemid vs. Steroid for the Management Knee Osteoarthritis

NCT07118501Recruiting

A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System

NCT03167502Not ApplicableCompletedPrimary

Performance in Walking in Osteoarthritis Patients

NCT07404891Not ApplicableRecruitingPrimary

Clinical Trial on the Efficacy and Safety of ALT001 in Osteoarthritis

NCT07353931Phase 3RecruitingPrimary

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

NCT07153471Phase 3RecruitingPrimary

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

NCT06451120Phase 2RecruitingPrimary

Platelet Rich Plasma Injections In Young And Old Human Subjects

NCT06550024Not ApplicableActive Not Recruiting

SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization

NCT05449132Phase 3CompletedPrimary

Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the Knee

NCT05248386Phase 3CompletedPrimary

Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee Osteoarthritis

NCT07473414Not ApplicableNot Yet RecruitingPrimary

Synovial Tissue as a Biomarker in the Early Management of Osteoarthritis

Scroll to load more

Research Network

Activity Timeline